We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$19.3B
AUM Growth
+$1.53B
Cap. Flow
+$473M
Cap. Flow %
2.45%
Top 10 Hldgs %
16.98%
Holding
3,283
New
233
Increased
1,447
Reduced
1,348
Closed
182

Sector Composition

Rank Sector Weight
1 Technology 7.96%
2 Financials 4.93%
3 Healthcare 4.48%
4 Consumer Discretionary 3.58%
5 Consumer Staples 3.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRX
2201
DELISTED
Catalyst Pharmaceutical
CPRX
$399K ﹤0.01%
+21,457
New +$330K
IVOG icon
2202
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.73B
$398K ﹤0.01%
4,704
+1,392
+42% +$119K
LRGE icon
2203
ClearBridge Large Cap Growth Select ETF
LRGE
$389M
$398K ﹤0.01%
9,749
+1,191
+14% +$49.9K
NHI icon
2204
National Health Investors
NHI
$3.5B
$398K ﹤0.01%
7,622
-564
-7% -$30.9K
QLTA icon
2205
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.22B
$398K ﹤0.01%
8,592
+3,220
+60% +$148K
FLNA
2206
Filana Therapeutics
FLNA
$45.7M
$398K ﹤0.01%
13,458
-1,150
-8% -$41.3K
TKR icon
2207
Timken Company
TKR
$9.1B
$398K ﹤0.01%
5,626
-1,198
-18% -$83.7K
SNAP icon
2208
Snap
SNAP
$8.96B
$397K ﹤0.01%
44,368
-3,071
-6% -$30.3K
WINC
2209
DELISTED
Western Asset Short Duration Income ETF
WINC
$397K ﹤0.01%
16,945
-897
-5% -$20.9K
MTUS icon
2210
Metallus
MTUS
$892M
$396K ﹤0.01%
21,769
+3,117
+17% +$55.3K
LSXMK
2211
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$396K ﹤0.01%
13,057
+71
+0.5% +$2.27K
KRTX
2212
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$396K ﹤0.01%
2,016
-40
-2% -$8.58K
KGC icon
2213
Kinross Gold
KGC
$31.9B
$395K ﹤0.01%
96,491
+34,351
+55% +$136K
CATH icon
2214
Global X S&P 500 Catholic Values ETF
CATH
$1.36B
$394K ﹤0.01%
8,467
+1,751
+26% +$82.2K
HOG icon
2215
Harley-Davidson
HOG
$2.9B
$394K ﹤0.01%
9,465
-4,080
-30% -$174K
JCE icon
2216
Nuveen Core Equity Alpha Fund
JCE
$293M
$394K ﹤0.01%
29,067
+8,269
+40% +$113K
PBF icon
2217
PBF Energy
PBF
$8.81B
$394K ﹤0.01%
+9,659
New +$402K
SGI
2218
Somnigroup International
SGI
$14B
$394K ﹤0.01%
11,476
-5,282
-32% -$159K
CSR
2219
Centerspace
CSR
$939M
$393K ﹤0.01%
6,704
+1,184
+21% +$76.5K
CSWC icon
2220
Capital Southwest
CSWC
$1.61B
$393K ﹤0.01%
22,969
-2,082
-8% -$37.2K
KIE icon
2221
State Street SPDR S&P Insurance ETF
KIE
$681M
$393K ﹤0.01%
9,605
+18
+0.2% +$726
TDTF icon
2222
FlexShares iBoxx 5-Year Target Duration TIPS Index Fund
TDTF
$1.04B
$393K ﹤0.01%
16,625
+841
+5% +$20K
MCBC
2223
DELISTED
Macatawa Bank Corp
MCBC
$393K ﹤0.01%
35,650
-21,923
-38% -$233K
ACLS icon
2224
Axcelis
ACLS
$4.42B
$392K ﹤0.01%
4,935
-281
-5% -$19.8K
CORP icon
2225
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
$392K ﹤0.01%
4,220
+1,420
+51% +$131K

Similar funds

Cambridge Investment Research Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Cambridge Investment Research Advisors held 3,283 positions worth $19.3B, up 8.6% from $17.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Cambridge Investment Research Advisors's Q4 2022 filing shows 233 new, 1,447 increased, 1,348 reduced and 182 closed positions. Its largest new stake was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M. The largest sale was Vanguard Short-Term Treasury ETF, an estimated $22.3M.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 8.9% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q4 2022 buy was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M.
  • Cambridge Investment Research Advisors added most to iShares 0-3 Month Treasury Bond ETF in Q4 2022, an estimated $66.9M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2022 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $22.3M.
  • Cambridge Investment Research Advisors fully exited Invesco BulletShares 2022 Corporate Bond ETF in Q4 2022, selling an estimated $12.7M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 17% of its $19.3B portfolio in Q4 2022.
  • Cambridge Investment Research Advisors opened 233 new positions and closed 182 in Q4 2022.
  • Cambridge Investment Research Advisors's portfolio value rose 8.6% quarter-over-quarter to $19.3B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.